DE60006284D1 - Arzneimittel zur behandlung konvulsivischer zustände - Google Patents

Arzneimittel zur behandlung konvulsivischer zustände

Info

Publication number
DE60006284D1
DE60006284D1 DE60006284T DE60006284T DE60006284D1 DE 60006284 D1 DE60006284 D1 DE 60006284D1 DE 60006284 T DE60006284 T DE 60006284T DE 60006284 T DE60006284 T DE 60006284T DE 60006284 D1 DE60006284 D1 DE 60006284D1
Authority
DE
Germany
Prior art keywords
medicinal products
convulsive states
treating convulsive
treating
states
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60006284T
Other languages
English (en)
Other versions
DE60006284T2 (de
Inventor
Elizabeth Janina Davidson
Fiona Craig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech Pharma Europe Ltd
Original Assignee
Celltech Pharma Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929981.0A external-priority patent/GB9929981D0/en
Priority claimed from GB0019061A external-priority patent/GB0019061D0/en
Application filed by Celltech Pharma Europe Ltd filed Critical Celltech Pharma Europe Ltd
Publication of DE60006284D1 publication Critical patent/DE60006284D1/de
Application granted granted Critical
Publication of DE60006284T2 publication Critical patent/DE60006284T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
DE60006284T 1999-12-17 2000-12-15 Arzneimittel zur behandlung konvulsivischer zustände Expired - Fee Related DE60006284T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9929981.0A GB9929981D0 (en) 1999-12-17 1999-12-17 The treatment of convulsive states
GB9929981 1999-12-17
GB0019061A GB0019061D0 (en) 2000-08-03 2000-08-03 The treatment of convulsive states
GB0019061 2000-08-03
PCT/GB2000/004838 WO2001043730A2 (en) 1999-12-17 2000-12-15 The treatment of convulsive states

Publications (2)

Publication Number Publication Date
DE60006284D1 true DE60006284D1 (de) 2003-12-04
DE60006284T2 DE60006284T2 (de) 2004-07-29

Family

ID=26244786

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006284T Expired - Fee Related DE60006284T2 (de) 1999-12-17 2000-12-15 Arzneimittel zur behandlung konvulsivischer zustände

Country Status (7)

Country Link
US (1) US7384959B2 (de)
EP (1) EP1239858B1 (de)
AT (1) ATE252903T1 (de)
AU (1) AU2199901A (de)
DE (1) DE60006284T2 (de)
ES (1) ES2210025T3 (de)
WO (1) WO2001043730A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486177B2 (en) 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
JP2004507503A (ja) * 2000-08-28 2004-03-11 センション，インコーポレイテッド 記憶を増強するためのトレオ−メチルフェニデートの使用
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
JPWO2014203696A1 (ja) * 2013-06-20 2017-02-23 国立大学法人 岡山大学 抗てんかん薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9805870A (de) 1996-01-22 1999-01-31
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Also Published As

Publication number Publication date
AU2199901A (en) 2001-06-25
EP1239858B1 (de) 2003-10-29
EP1239858A2 (de) 2002-09-18
WO2001043730A3 (en) 2002-06-13
ES2210025T3 (es) 2004-07-01
ATE252903T1 (de) 2003-11-15
WO2001043730A2 (en) 2001-06-21
DE60006284T2 (de) 2004-07-29
US7384959B2 (en) 2008-06-10
US20030162810A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
AU7031500A (en) Therapeutic quinazoline compounds
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60027894D1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
GB0005251D0 (en) Therapeutic compounds
PT915898E (pt) Forma i cristalina de claritromicina
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
MY138883A (en) Use of asiatic acid for treatment of cencer
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
WO2001081332A3 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
GB9907571D0 (en) Compounds
DE60006284D1 (de) Arzneimittel zur behandlung konvulsivischer zustände
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
ATE234613T1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
MXPA02004699A (es) Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
HK1050203A1 (en) Novel fusidic acid derivatives.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee